Gastrointestinal Diseases (Functional Gastrointestinal Disorders)

Subscribe to Selected New Research on Gastrointestinal Diseases

1230 relevant articles (47 outcomes, 99 trials/studies) found for this Disease

Description: Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.

Also Known As:

Functional Gastrointestinal Disorders; Gastrointestinal Disorders, Functional; Disease, Gastrointestinal; Diseases, Gastrointestinal; Disorder, Functional Gastrointestinal; Disorders, Functional Gastrointestinal; Functional Gastrointestinal Disorder; Gastrointestinal Disease; Gastrointestinal Disorder, Functional; Infantum, Cholera; Cholera Infantum

Relationship Network

Disease Context: Research Results

Digestive System Diseases: 31

Gastrointestinal Diseases: 1230

Peptic Ulcer: 6982

Gastroenteritis: 1813

Gastrointestinal Neoplasms: 1591

Gastrointestinal Hemorrhage: 854

Intestinal Diseases: 601

Stomach Diseases: 370

Esophageal Diseases: 109

Gastrointestinal Tuberculosis: 15

Visceral Prolapse: 2

Related Diseases

1.	Pain (Aches)
2.	Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
3.	Neoplasms (Cancer)
4.	Acquired Immunodeficiency Syndrome (AIDS)
5.	Dyspepsia (Indigestion)

Experts

1.	Gravante, G: 2 articles (02/2008 - 12/2006)
2.	Venditti, D: 2 articles (02/2008 - 12/2006)
3.	Delogu, D: 2 articles (02/2008 - 12/2006)
4.	Kamali-Sarvestani, Eskandar: 2 articles (09/2007 - 08/2006)
5.	Taghavi, Ali-Reza: 2 articles (09/2007 - 08/2006)
6.	Bazargani, Abdulah: 2 articles (09/2007 - 08/2006)
7.	Lankarani, Kamran: 2 articles (09/2007 - 08/2006)
8.	Saberifiroozi, Mehdi: 2 articles (09/2007 - 08/2006)
9.	Sarker, Mahfuzur R: 2 articles (04/2007 - 05/2005)
10.	Fisher, Derek J: 2 articles (02/2006 - 05/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Gastrointestinal Diseases:

1.	Antidepressive Agents (Antidepressants)IBA 02/01/2009 - "Several studies have suggested that antidepressants might be beneficial in the treatment of patients with functional gastrointestinal disorders. " 01/01/2000 - "CONCLUSION: Treatment of functional gastrointestinal disorders with antidepressants appears to be effective. " 01/01/2000 - "METHODS: We performed a meta-analysis of published, English-language, randomized clinical trials on the use of antidepressants for the treatment of patients with functional gastrointestinal disorders. " 02/01/2007 - "CONCLUSIONS: Failure to maintain treatment occurs in nearly a quarter of outpatients given antidepressants for functional gastrointestinal disorders. " 02/01/2007 - "Antidepressants are being used increasingly to manage patients with functional gastrointestinal disorders; poor patient adherence to treatment regimens, particularly in the period shortly after antidepressant initiation, is common and interferes with success. " Order ALL the reference details at left...
2.	Ganciclovir (Cytovene)FDA LinkGeneric 08/01/1987 - "Ganciclovir may be effective in treating cytomegalovirus gastrointestinal disease in patients with the acquired immunodeficiency syndrome." 04/01/1988 - "Extensive trials with intravenous ganciclovir, a nucleoside analogue with myelosuppressive toxicity, have shown that ganciclovir halts the progression of cytomegalovirus retinitis and gastrointestinal disease. " 04/01/1993 - "Nineteen male homosexuals with AIDS and biopsy-proven CMV gastrointestinal disease who had twice failed standard ganciclovir induction (defined as progression of clinical CMV disease) were studied. " 09/01/1990 - "Favorable clinical responses to ganciclovir have been reported in approximately 80% of immunocompromised patients with CMV retinitis or gastrointestinal disease. " 06/01/1988 - "In both retinitis and gastrointestinal disease patients, ganciclovir decreased recovery of CMV from urine and blood markedly. " Order ALL the reference details at left...
3.	Foscarnet FDA LinkGeneric 06/01/1997 - "Twice-daily foscarnet appeared to be safe and efficacious in the treatment of CMV gastrointestinal disease in this study, resulting in endoscopic or histologic improvement in 9 of the 10 (90%) patients. " 07/01/1995 - "For HCMV gastrointestinal disease, complete or partial response rates of 57-95% have been reported with foscarnet. " 04/01/1993 - "Foscarnet appears to induce remission of CMV gastrointestinal disease in 67% of patients when ganciclovir induction has failed. " 09/01/1995 - "Patients with symptomatic gastrointestinal disease due to cytomegalovirus (CMV) were randomized to receive open-label ganciclovir (22) or foscarnet (26). " 04/01/1993 - "This compassionate-use study examined the efficacy of foscarnet in patients with AIDS and cytomegalovirus (CMV) gastrointestinal disease who had failed ganciclovir induction. " Order ALL the reference details at left...
4.	rifaximin (L 105)FDA Link 02/15/2006 - "Additional studies should be performed to further define the role of rifaximin in the treatment of gastrointestinal diseases in adults and children." 10/24/2004 - "According to the clinical studies rifaximin could be an adequate therapeutic approach in all gastrointestinal diseases and interventions when antibacterial therapy is needed." 01/01/2005 - "This article highlights several studies demonstrating the efficacy of rifaximin in treating travelers' diarrhea as well as other gastrointestinal diseases and discusses the drug's pharmacokinetics, indications, contraindications, warnings, precautions, adverse reactions, and dosing." 06/01/2009 - "Rifaximin contributes to restore gut microflora imbalance, becoming an important therapeutic agent in several organic and functional gastrointestinal diseases such as hepatic encephalopathy, small intestine bacterial overgrowth, inflammatory bowel disease and colonic diverticular disease. " 07/01/2000 - "CONCLUSION: The low toxicity, broad antibacterial activity and very poor absorption from the gastrointestinal tract of rifaximin suggest a potential therapeutic use for this drug in gastrointestinal diseases, as well as in the management of patients with cirrhosis and chronic portal-systemic encephalopathy." Order ALL the reference details at left...
5.	Lactose FDA LinkGeneric 11/01/2006 - "Although rare, intolerance to lactose should be considered in the differential diagnosis of gastrointestinal diseases that can cause malabsorption of LT(4). " 03/01/1982 - "Of 123 children with chronic gastrointestinal diseases examined on an inpatient basis, 65 (53%) showed lactose hydrolysis disorder. " 01/01/1983 - "The frequency of lactose intolerance was studied in patients with chronic gastrointestinal disease, mainly peptic ulcer to explore the possibilities of the use of lactose-poor milk. " 03/01/1985 - "Considering 50 children affected by sub-acute gastrointestinal diseases by severe growth disorders, we have compared the "one-hour blood xylose test" with the "xylose and lactose H2 breath test, looking for a relationship with the duodeno-jejunal mucosal damage. " 08/01/1990 - "3. In 143 patients with gastrointestinal disease, excretion of both ingested raffinose and lactose was significantly increased in coeliac disease in relapse or in partial remission and in Crohn's disease, but not in the irritable bowel syndrome, coeliac disease in remission or ulcerative colitis. " Order ALL the reference details at left...
6.	EnterotoxinsIBA 11/01/2005 - "An enterotoxin (cpe) plasmid was cured from a Clostridium perfringens non-food-borne gastrointestinal disease (NFBGID) isolate, and the heat resistance levels of wild-type, cpe knockout, and cpe plasmid-cured strains were compared. " 02/01/2006 - "Complete sequencing and diversity analysis of the enterotoxin-encoding plasmids in Clostridium perfringens type A non-food-borne human gastrointestinal disease isolates." 05/01/2005 - "Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene." 01/01/1998 - "Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with non-food-borne human gastrointestinal diseases." 06/01/2009 - "perfringens enterotoxin, an important virulence factor for food poisoning and nonfood-borne gastrointestinal diseases in humans. " Order ALL the reference details at left...
7.	Glutamine (L-Glutamine)FDA Link 01/01/2007 - "AUTHORS' CONCLUSIONS: The available data from randomised controlled trials are not sufficient to determine whether glutamine supplementation confers clinically significant benefits for infants with severe gastrointestinal disease. " 01/01/2007 - "OBJECTIVES: To assess the evidence from randomised controlled trials that providing supplemental glutamine reduces mortality and morbidity in infants with severe gastrointestinal disease. " 01/01/2007 - "Studies using animal models of gastrointestinal disease and controlled trials in adult patients have suggested that glutamine supplementation improves clinical outcomes. " 09/01/2004 - "Glutamine supplementation in infants with gastrointestinal disease: a randomized, placebo-controlled pilot trial." 09/01/2000 - "Emerging clinical trials will further define the utility of adjunctive glutamine supplementation as a component of specialized nutrition support in gastrointestinal disease." Order ALL the reference details at left...
8.	Carbon MonoxideIBA 01/06/1977 - "It is postulated that the RCT's in gastroenterology are quantitatively and qualitatively insufficient and that co-ordinated planning of RCT's and uninhibited publication of statistically proved negative results may help to ensure that the patient with gastrointestinal disease receives the best available treatment." 10/01/2005 - "Demographic information, indications, previous gastrointestinal disease, serious co-morbidity and concomitant prescriptions were recorded. " 09/01/2007 - "Patients with human immunodeficiency virus co-infection and gastrointestinal disease or diarrhoea were excluded. " 05/01/2004 - "Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder with a high co-occurrence with affective dysregulation. " 03/01/1975 - " Histoplasmosis should be included in the differential diagnosis of diseases presenting with a malabsorption pattern, gastrointestinal polyposis, ulcerative and granulomatous gastrointestinal diseases and carcinoma, particularly if pulmonary lesions co-exist." Order ALL the reference details at left...
9.	BariumIBA 05/01/1998 - "The major emphasis of the article, however, is to demonstrate classic barium imaging of a large number of gastrointestinal disease processes." 08/01/1980 - "Colonoscopically verified lesions (230 in 178 patients) were reviewed and compared to results of double-contrast barium enema studies performed by radiologists specifically interested in gastrointestinal disease. " 12/01/1976 - "Barium studies are most helpful in the diagnosis of unexpected gastrointestinal disease in asymptomatic patients, but of little value in cases of massive gastrointestinal hemorrhage. " 10/01/1985 - "The purpose of the study was to compare the history of rectal bleeding during the year before the study and the presence of faecal occult bleeding in patients with advanced diverticular disease of the large bowel and two sex- and age-matched reference groups, one consisting of patients with normal large-bowel barium enemas and the other of persons without any history of gastrointestinal disease. " 03/01/2000 - "Pros and cons of barium-impregnated polyethylene spheres in gastrointestinal disease." Order ALL the reference details at left...
10.	AntibodiesIBA 01/01/2009 - "AIM: To examine content, diagnostic and prognostic role of autologous antibodies in gastrointestinal diseases (GID). " 10/01/2005 - "AIM: A high rate of seropositivity for antibodies against Helicobacter pylori has been found in many extra-gastrointestinal diseases. " 06/01/2000 - "* Detection of anti-enteric neuronal antibodies may be a useful diagnostic test for early stages of inflammatory degenerative neuropathy in patients with symptoms of a functional gastrointestinal disorder. " 01/01/1999 - "AIM: To measure circulating antibodies to yeast organisms that could be used to characterise the yeast specific immune response in gastrointestinal disease. " 01/01/1999 - "Circulating antibodies to Saccharomyces cerevisiae (bakers'/brewers' yeast) in gastrointestinal disease." Order ALL the reference details at left...

Therapies and Procedures

1.	Parenteral Nutrition 05/01/2002 - "Therefore, the hypothesis that parenteral nutrition (PN) is beneficial for horses with severe gastrointestinal disease was investigated in a retrospective study. " 06/01/1991 - "The present study investigated the effects of two modalities of parenteral nutrition (continuous nutrition over the 24-hour period vs. cyclic nutrition, i.e., administered only during the night) on O2 consumption during sleep in children affected by severe gastrointestinal diseases. " 05/01/2002 - "Parenteral nutrition for horses with gastrointestinal disease: a retrospective study of 79 cases." 03/01/1999 - "Our conclusion is that parenteral nutrition does not affect oral intake in patients without underlying gastrointestinal disease." 09/01/1997 - "In the absence of any alternative treatment for many patients with gastrointestinal disease, parenteral nutrition is life saving and offers the prospect of maintaining a good quality of life. " Order ALL the reference details at left...
2.	Drug Therapy (Chemotherapy) 03/01/1998 - "The best treatment of CMV gastrointestinal disease has been controversial, with some centers adding intravenous (i.v.) Ig to antiviral chemotherapy. " 04/01/2009 - "Pharmacotherapy for functional gastrointestinal disorders in children." 12/01/2007 - "CONCLUSION: In refractory autoimmune gastrointestinal diseases, it seems that high-dose chemotherapy followed by HSCT is feasible and safe and might result in long-term improvement of disease activity." 12/01/2006 - "Pharmacotherapy for functional gastrointestinal disorders in children." 07/01/2004 - "Adjusted medical costs and healthcare use related to gastrointestinal disease (measured by office visits, endoscopy, or imaging and hospital admissions) and factors associated with initial and subsequent drug therapy were analyzed using a 2-stage model. " Order ALL the reference details at left...
3.	Transplants (Transplant) 07/01/1982 - "Delayed onset of gastrointestinal disease in the recipients of bone marrow transplants. " 08/01/2008 - "Among patients with solid organ transplants, CMV has become an increasingly important cause of gastrointestinal disease as more routine use of early CMV prophylaxis has increased delayed-onset disease, which is often tissue invasive at presentation. " 02/01/2008 - "BACKGROUND: The incidence and risk factors of gastrointestinal diseases in pre-liver transplant population are still a matter of debate. " 02/01/2008 - "Upper and lower gastrointestinal diseases in liver transplant candidates." 07/01/1999 - "We reviewed our experience with gastrointestinal disease in 92 patients undergoing 93 heart transplants. " Order ALL the reference details at left...
4.	Nutritional Support (Artificial Feeding) 09/01/1998 - "Home artificial nutritional support in gastrointestinal disease." 08/01/1989 - "Enteral and parenteral nutritional support in dogs and cats with gastrointestinal disease." 06/01/1989 - "The use of nutritional support in patients with acute gastrointestinal disease requires a thorough knowledge of the pathophysiology and nutritional alterations that are caused by the disease process. " 06/01/1989 - "Nutritional support and gastrointestinal disease." 09/01/1982 - "Nutritional support of patients with gastrointestinal disease." Order ALL the reference details at left...
5.	Enteral Nutrition (Feeding, Tube) 12/01/2000 - "We conclude that enteral nutrition is very useful for gastrointestinal disease, but that social problems affect home care with enteral nutrition." 01/01/2007 - "[Enteral nutrition in the therapy of gastrointestinal diseases (according to materials of the European Association of Parenteral and Enteral Nutrition)]" 05/01/2001 - "[Parenteral and enteral nutrition in children with gastrointestinal diseases]" 12/01/2000 - "[Enteral nutrition for gastrointestinal disease in home care]" 05/01/1998 - "[Enteral nutrition in gastrointestinal disease]" Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Gastrointestinal Diseases

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 47 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>